Profit Or Loss [Abstract]

Egetis Therapeutics - Filing #701621

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
38 243 SEK
40 662 SEK
Other income
300,000 SEK
0 SEK
Employee benefits expense
30 131 SEK
22 151 SEK
Other expenses, by nature
14 513 SEK
10 001 SEK
Profit (loss) from operating activities
105 681 SEK
177 299 SEK
Finance income
1 327 SEK
163,000 SEK
Finance costs
188,000 SEK
888,000 SEK
Profit (loss) before tax
104 542 SEK
178 024 SEK
Tax expense (income)
- SEK
- SEK
Profit (loss)
104 542 SEK
178 024 SEK
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
6.0
26.0
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
6.0
26.0

Talk to a Data Expert

Have a question? We'll get back to you promptly.